Network Pharmacology Study on Mechanism of Danggui Sinitang in Treating Hepatocellular Carcinoma

Ze-yu LIU; Yu-xiang WAN; Jin-chang HUANG

doi:10.13422/j.cnki.syfjx.20200124

您当前的位置：

首页 >

文章列表页 >

Network Pharmacology Study on Mechanism of Danggui Sinitang in Treating Hepatocellular Carcinoma

Data Mining | 更新时间：2021-02-09

- Network Pharmacology Study on Mechanism of Danggui Sinitang in Treating Hepatocellular Carcinoma
- Chinese Journal of Experimental Traditional Medical Formulae Vol. 26, Issue 6, Pages: 185-192(2020)
- 作者机构：
  
  北京中医药大学　第三附属医院，北京　 100029
- 作者简介：
- 基金信息：
- DOI：10.13422/j.cnki.syfjx.20200124
  CLC： R22; R242; R2-031;R285.5
- Received：17 June 2019，
  
  Published Online：18 September 2019，
  
  Published：20 March 2020
- 稿件说明：
移动端阅览
Ze-yu LIU, Yu-xiang WAN, Jin-chang HUANG. Network Pharmacology Study on Mechanism of Danggui Sinitang in Treating Hepatocellular Carcinoma[J]. Chinese journal of experimental traditional medical formulae, 2020, 26(6): 185-192.
DOI：

Ze-yu LIU, Yu-xiang WAN, Jin-chang HUANG. Network Pharmacology Study on Mechanism of Danggui Sinitang in Treating Hepatocellular Carcinoma[J]. Chinese journal of experimental traditional medical formulae, 2020, 26(6): 185-192. DOI： 10.13422/j.cnki.syfjx.20200124.

摘要

目的：

通过对当归四逆汤的网络药理学分析，探讨当归四逆汤治疗肝细胞癌的潜在抗肿瘤靶点及作用机制，为后续研究提供有针对性的指导。

方法：

利用Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform(TCMSP)网站及SwissTargetPrediction网站建立当归四逆汤有效成分及靶点数据库，利用Comparative Toxicogenomics Database(CTD)，Therapeutic Target Database(TTD)，Human Phenotype Ontology(HPO)网站建立肝细胞癌相关靶点数据库，并与当归四逆汤靶点数据库相匹配。在匹配结果的基础上，应用STRING网站分析靶标之间的相互作用，并利用The Database for Annotation

Visualization and Integrated Discovery(DAVID)网站进行基因本体论(gene ontology，GO)生物学过程分析和京都基因与基因组百科全书(Kyoto Encyclopedia of Genes and Genomes，KEGG)通路富集分析，运用Cytoscape 3.6.0软件进行网络分析。

结果：

共发现当归四逆汤治疗肝细胞癌的56个可能的重要靶点，经GO富集分析得到106个细胞生物学过程，经KEGG富集分析得到23个相关通路，其中主要包括TNF信号通路，FoxO信号通路，Toll样受体信号通路，p53信号通路，磷脂酰肌醇3激酶(PI3K)/蛋白激酶B(Akt)信号通路，腺苷酸激活蛋白激酶(AMPK)信号通路，两面神激酶(JAK)/信号传导及转录激活因子(STAT)信号通路等。

结论：

当归四逆汤对肝细胞癌的治疗作用可能是多靶点、多途径、多层次的。并且可以推测槲皮素和山柰酚可能是其中比较重要的2个有效成分，PI3K/Akt信号通路和MAPK信号通路可能是本方发挥作用比较重要的两条信号通路。本研究不仅有助于更好地理解当归四逆汤抗肝细胞癌的作用机制，而且提供了利用网络药理学开发新的中医药候选药物的策略。

Abstract

Objective:

This paper aims to explore the potential anti-neoplasm targets and mechanism of Danggui Sinitang on hepatocellular carcinoma by analyzing the prescription of Danggui Sinitang with the method of network pharmacology

in order to provide targeted guidance for further studies.

Method:

The Traditional Chinese Medicine System Platform (TCMSP) and SwissTargetPrediction database were adopted to establish the database of Danggui Sinitang' s effective ingredients and targets. The Comparative Toxicogenomics Database (CTD)

Therapeutic Target Database (TTD)

and Human Phenotype Ontology (HPO) were used to build the hepatocellular carcinoma target database

which was then matched with Danggui Sinitang' s target database. Based on the matching results

STRING database was applied to analyze the interactions between the targets and the Database for Annotation

Visualization and Integrated Discovery (DAVID) was utilized for the enrichment analysis on gene ontology (GO) biological process and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway. Then Cytoscape 3.6.0 software was used for networks analysis.

Result:

A total of 56 significant targets of Danggui Sinitang were found for treatment of hepatocellular carcinoma. The 106 cellular biological processes were obtained through GO biological process enrichment analysis and 23 related pathways were obtained by KEGG enrichment analysis

mainly including TNF signaling pathway

FoxO signaling pathway

Toll-like receptor signaling pathway

p53 signaling pathway

phosphatidylinositol-3-kinases(PI3K)/protein kinase B(Akt) signaling pathway

AMP activated protein kinase(AMPK) signaling pathway

Janus kinase(JAK)/signal transducer and activator of transcription(STAT) signaling pathway

et al.

Conclusion:

The therapeutic effect of Danggui Sinitang on hepatocellular carcinoma may be multi-target

multi-channel and multi-level. It can be inferred that quercetin and kaempferol may be two important active components

and PI3K/Akt signaling pathway and MAPK signaling pathway may be two important signaling pathways. This study not only makes a contribution to a better understanding of the anti-hepatocellular carcinoma mechanism of Danggui Sinitang

but also proposes a strategy to develop new TCM candidates at a network pharmacology level.

关键词

Keywords

references

L A TORRE , F BRAY , R L SIEGEL , et al . Global cancer statistics, 2012 [J]. CA Cancer J Clin ， 2015 ， 65 ( 2 ): 87 - 108 .

W CHEN , R ZHENG , P D BAADE , et al . Cancer statistics in China, 2015 [J]. CA Cancer J Clin ， 2016 ， 66 ( 2 ): 115 - 132 .

M C WALLACE , D PREEN , P J GARY , et al . The evolving epidemiology of hepatocellular carcinoma: a global perspective [J]. Expert Rev Gastroenterol Hepatol ， 2015 ， 9 ( 6 ): 765 - 779 .

S F ALTEKRUSE , S S DEVESA , L A DICKIE , et al . Histological classification of liver and intrahepatic bile duct cancers in SEER registries [J]. J Registry Manag ， 2011 ， 38 ( 4 ): 201 - 205 .

李相成，李长贤，张嘉伟，等．多模式治疗肝细胞肝癌的共识与争议 [J]．中国实用外科杂志， 2018 ， 38 ( 1 ): 41 - 44 .

张靖，李红法，樊威，等．抗肝癌中药古方用药规律统计及抗肝癌新药研发风险评估 [J]．中国中药杂志， 2014 ， 39 ( 19 ): 3870 - 3875 .

杨树明，幼明．当归四逆汤治疗癌痛50例 [J]．实用中医药杂志， 1994 ( 5 ): 47 .

A L HOPKINS . Network pharmacology: the next paradigm in drug discovery [J]. Nat Chem Biol ， 2008 ， 4 ( 11 ): 682 - 690 .

刘雨晴，王爱帅，蒋珊，等．基于网络药理学探讨夏枯草对非小细胞肺癌的作用机制 [J]．中国实验方剂学杂志， 2019 ， doi: org/10.13422/j.cnki.syfjx.20192024 http://dx.doi.org/10.13422/j.cnki.syfjx.20192024 .

余平，郑建红，楼婷婷．基于网络药理学六君子汤治疗胃癌的物质基础与作用机制研究 [J]．中国现代应用药学， 2019 ， 36 ( 12 ): 1508 - 1515 .

J RU , P LI , J WANG , et al . TCMSP: a database of systems pharmacology for drug discovery from herbal medicines [J]. J Cheminform ， 2014 ， 6 ( 1 ): 13 .

D GFELLER , O MICHIELIN , V ZOETE . Shaping the interaction landscape of bioactive molecules [J]. Bioinformatics ， 2013 ， 29 ( 23 ): 3073 - 3079 .

Y H LI , C Y YU , X X LI , et al . Therapeutic target database update 2018: enriched resource for facilitating bench-to-clinic research of targeted therapeutics [J]. Nucleic Acids Res ， 2018 ， 46 ( D1 ): D1121 - D1127 .

C J GRODIN , A P DAVIS , T C WIEGERS , et al . Accessing an expanded exposure science module at the comparative toxicogenomics database [J]. Environ Health Perspect ， 2018 ， 126 ( 1 ): 014501 .

P N ROBINSON , S MUNDLOS . The human phenotype ontology [J]. Clin Genet ， 2010 ， 77 ( 6 ): 525 - 534 .

D SZKLARCZYK , J H MORRIS , H COOK , et al . The STRING database in 2017: quality-controlled protein-protein association networks, made broadly accessible [J]. Nucleic Acids Res ， 2017 ， 45 ( Database issue ): D362 - D368 .

P SHANNON , A MARKIEL , O OZIER , et al . Cytoscape: a software environment for integrated models of biomolecular interaction networks. [J]. Genome Res ， 2003 ， 13 ( 11 ): 2498 - 2504 .

D W HUANG , B T SHERMAN , R A LEMPICKI . Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. [J]. Nature Protocols ， 2009 ， 4 ( 1 ): 44 - 57 .

J WIXON , D KELL . The Kyoto encyclopedia of genes and genomes-KEGG [J]. Yeast ， 2000 ， 17 ( 1 ): 48 - 55 .

E KASHAFI , M MORADZADEH , A MOHAMADKHANI , et al . Kaempferol increases apoptosis in human cervical cancer HeLa cells via PI3K/Akt and telomerase pathways [J]. Biomed Pharmacother ， 2017 ， 89 : 573 - 577 .

陈兆勋，高彦宇，李冀．不同浓度槲皮素对人肝癌细胞株Hep3B、Huh7细胞凋亡的影响 [J]．中医杂志， 2015 ， 56 ( 12 ): 1051 - 1053 .

陈鹏，阳锡军，李春满，等．槲皮素对裸鼠肝癌切除术后肿瘤复发的影响及机制 [J]．昆明医科大学学报， 2017 ， 38 ( 11 ): 25 - 28 .

陈飞宇，李澎，甘加宽，等．桦木酸对人肝癌HepG2肿瘤干细胞增殖的影响 [J]．中国中医药信息杂志， 2017 ， 24 ( 2 ): 60 - 64 .

孙玉成，刘晓巍，片光哲． β -谷甾醇诱导人胃癌细胞自噬与凋亡的作用及机制研究 [J]．中国医师杂志， 2019 ， 21 ( 6 ): 866 - 871 .

J R PATIL , G K JAYAPRAKASHA , K N C MURTHY , et al . Characterization of Citrus aurantifolia bioactive compounds and their inhibition of human pancreatic cancer cells through apoptosis [J]. Microchemical Journal ， 2010 ， 94 ( 2 ): 108 - 117 .

F PENE , Y E CLAESSENS , O MULLER , et al . Role of the phosphatidylinositol 3-kinase/Akt and mTOR/P70S6-kinase pathways in the proliferation and apoptosis in multiple myeloma [J]. Oncogene ， 2002 , 21 ( 43 ): 6587 - 6597 .

M M HILL , B A HEMMINGS . Inhibition of protein kinase B/Akt implications for cancer therapy [J]. Pharmacol Ther ， 2002 ， 93 ( 2/3 ): 243 - 251 .

B H JIANG , L Z LIU . PI3K/PTEN signaling in angiogenesis and tumorigenesis [J]. Adv Cancer Res ， 2009 ， 102 ( 1 ): 19 - 65 .

T BORSELLO , G FORLONI . JNK signalling: a possible target to prevent neurodegeneration [J]. Curr Pharm Des ， 2007 ， 13 ( 18 ): 1875 - 1886 .

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Clinical Efficacy and Mechanism of Compound Langdu Tincture in Treating Multiple Palmoplantar Warts of Dampness-toxin Accumulation Type

Excavation of New Prescription for Chronic Atrophic Gastritis and Its Verification of Syndrome Type of Deficiency of Stomach Yin

Mahoniae Caulis Alkaloids Ameliorate Depression by Regulating Synaptic Plasticity via cAMP Pathway

Analysis of Potential Active Components and Molecular Mechanism of Baoxin Granules Regulating Ferroptosis in Treatment of Heart Failure

Effect and Mechanism of Angelicae Sinensis Radix-Polygonati Rhizoma Herb Pair in Treatment of Simple Obesity

Related Author

ZHENG Yuping

ZHANG Yanfeng

GENG Lanxin

TAO Maocan

HE Xiang

SHAO Changming

WANG Hongyu

XIE Shanshan

Related Institution

The First Affiliated Hospital of Zhejiang Chinese Medical University （Zhejiang Provincial Hospital of Chinese Medicine）

Shanghai Pudong New Area Guangming Traditional Chinese Medicine（TCM） Hospital

Shuguang Hospital Affiliated to Shanghai University of TCM

College of Traditional Chinese Medicine， Xinjiang Medical University

Medical Department of Integrated Traditional Chinese and Western Medicine Hospital of Xinjiang Uygur Autonomous Region

AI问答

Postal code：100700
Tel：010-84076882 Email：syfjx_2010@188.com
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备11006657号-10 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰